51. Isolation of Burkholderia cenocepacia J 2315 from non-cystic fibrosis pediatric patients in India.
- Author
-
Satpute MG, Telang NV, Dhakephalkar PK, Niphadkar KB, and Joshi SG
- Subjects
- Anti-Bacterial Agents pharmacology, Bacteremia diagnosis, Bacteremia microbiology, Biofilms growth & development, Burkholderia Infections microbiology, Burkholderia cenocepacia drug effects, Burkholderia cenocepacia growth & development, Burkholderia cenocepacia physiology, Child, Child, Preschool, Community-Acquired Infections diagnosis, Community-Acquired Infections microbiology, Cross Infection diagnosis, Cross Infection microbiology, Drug Resistance, Multiple, Bacterial, Humans, Immunocompromised Host, India, Male, Burkholderia Infections diagnosis, Burkholderia cenocepacia isolation & purification, Lung Diseases complications, Lung Diseases microbiology
- Abstract
We report for the first time 2 cases of multidrug-resistant Burkholderia cenocepacia J2315 isolated from blood samples of patients without cystic fibrosis from a pediatric unit in a hospital in India. The first patient presented with community-acquired bacteremia, and the second patient was immunocompromised and developed hospital-acquired infection approximately 17 days after admission. The isolates from both patients were multidrug-resistant and strong biofilm producers. Surveillance cultures identified the secondary sources of the infections, but not the primary sources., (Copyright © 2011 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF